EPISODE · Apr 11, 2011 · 5 MIN
Are Lung Cancers with BRAF Mutations Another Molecularly Defined Subgroup of Patients?
from Journal of Clinical Oncology (JCO) Podcast
In this week's podcast, Dr. Jaine discusses the recent manuscript by Paik and colleagues evaluating BRAF mutations in patients with advanced lung cancer. The potential impact of BRAF mutations and outcomes with current therapies for lung cancer are discussed.
NOW PLAYING
Are Lung Cancers with BRAF Mutations Another Molecularly Defined Subgroup of Patients?
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m